
    
      This study is a combination of phases I and II. Phase I study is open-label, and only collect
      safety information of the investigational sIPVs in adults, children and infants. Phase II
      study is double-blind, randomized, controlled study of the immunogenicity and safety of the
      investigational vaccines and two other commercialized inactivated poliovirus vaccines in
      healthy infants.
    
  